Q32 Bio Inc. (QTTB) Insider Trading
Over the last 3 months, QTTB insiders made 0 open-market buys and 3 sales, a net sale of -$275K (SEC Form 4). Over the last 6 months, 12 institutions increased and 12 reduced their position (13F).
Insider Activity
Sentiment
0/100
Buys (3m)
0
Sells (3m)
3
Net (3m)
-$275.1K
Insider trades by month Buys Sells
Aug
Aug
Dec
Feb
Jun
Aug
Context3-month price +28.7%Institutions reducing (13F)
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Aug 27, 2026 | Violette Shelia M.officer: Chief Scientific Officer | Sell | 2,798 | $16.56 |
| Aug 27, 2026 | Morrison Jodie Popedirector, officer: CEO | Sell | 9,845 | $16.56 |
| Aug 27, 2026 | Kalowski Leeofficer: CFO and President | Sell | 3,972 | $16.56 |
| Jul 21, 2026 | Iwicki Mark Tdirector | Grant | 10,826 | $12.64 |
| Jul 21, 2026 | TZIANABOS ARTHURdirector | Grant | 10,826 | $12.64 |
| Jul 21, 2026 | Lundberg Sven Antedirector | Grant | 10,826 | $12.64 |
| Jul 21, 2026 | LAPORTE KATHLEENdirector | Grant | 10,826 | $12.64 |
| Jul 21, 2026 | Thistle Marydirector | Grant | 10,826 | $12.64 |
| Jul 21, 2026 | GRAYZEL DAVID S.director | Grant | 10,826 | $12.64 |
| Jul 21, 2026 | Manke Isaacdirector | Grant | 10,826 | $12.64 |
| Jul 21, 2026 | Xu Diyongdirector, 10 percent owner: | Grant | 10,826 | $12.64 |
| Jul 20, 2026 | Morrison Jodie Popedirector, officer: CEO | Grant | 132,000 | — |
| Jul 20, 2026 | Kalowski Leeofficer: CFO and President | Grant | 53,250 | — |
| Jul 20, 2026 | Violette Shelia M.officer: Chief Scientific Officer | Grant | 37,500 | — |
| Jul 2, 2026 | Manke Isaacdirector | Option | 53,521 | $2.80 |
| Jun 16, 2026 | LAPORTE KATHLEENdirector | Grant | 9,810 | $12.64 |
| Jun 16, 2026 | TZIANABOS ARTHURdirector | Grant | 9,810 | $12.64 |
| Jun 16, 2026 | GRAYZEL DAVID S.director | Grant | 9,810 | $12.64 |
| Jun 16, 2026 | Thistle Marydirector | Grant | 9,810 | $12.64 |
| Jun 16, 2026 | Xu Diyongdirector, 10 percent owner: | Grant | 9,810 | $12.64 |
| Jun 16, 2026 | Lundberg Sven Antedirector | Grant | 9,810 | $12.64 |
| Jun 16, 2026 | Iwicki Mark Tdirector | Grant | 9,810 | $12.64 |
| Jun 16, 2026 | Manke Isaacdirector | Grant | 9,810 | $12.64 |
| Jun 1, 2026 | ORBIMED ADVISORS LLCdirector, 10 percent owner: | Buy | 1,250,000 | $8.00 |
| Jun 1, 2026 | ORBIMED ADVISORS LLCdirector, 10 percent owner: | Buy | 625,000 | $8.00 |
| Jun 1, 2026 | Xu Diyongdirector, 10 percent owner: | Buy | 625,000 | $8.00 |
| Jun 1, 2026 | Xu Diyongdirector, 10 percent owner: | Buy | 1,250,000 | $8.00 |
| Mar 20, 2026 | Morrison Jodie Popedirector, officer: CEO | Grant | 132,000 | — |
| Mar 20, 2026 | Violette Shelia M.officer: Chief Scientific Officer | Grant | 37,500 | — |
| Mar 20, 2026 | Kalowski Leeofficer: CFO and President | Grant | 53,250 | — |
Source: QTTB SEC Form 4 filings, latest Aug 27, 2026. For informational purposes only — not investment advice.
Institutional activity (13F)
How institutions changed their QTTB positions over the last 6 months (SEC Form 13F).
Increased
12
New positions
11
Reduced
12
Sold out
52
Largest moves
| Institution | Action | Shares | Filed |
|---|---|---|---|
| ORBIMED ADVISORS LLC | Unchanged | 2.3M | May 15, 2026 |
| ATLAS VENTURE LIFE SCIENCE ADVISORS, LLC | Unchanged | 2.1M | May 14, 2026 |
| OPALEYE MANAGEMENT INC. | Increased | 1.3M | May 15, 2026 |
| CARLYLE GROUP INC. | Unchanged | 1.1M | May 8, 2026 |
| ARCH VENTURE MANAGEMENT, LLC | Unchanged | 320K | May 15, 2026 |
| ACORN CAPITAL ADVISORS, LLC | Reduced | 315K | May 15, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | New Position | 306K | May 15, 2026 |
| MACKENZIE FINANCIAL CORP | New Position | 246K | May 13, 2026 |
| SANOFI | Unchanged | 244K | May 7, 2026 |
| RENAISSANCE TECHNOLOGIES LLC | Increased | 207K | May 14, 2026 |
| ACADIAN ASSET MANAGEMENT LLC | Increased | 173K | May 13, 2026 |
| MONIMUS CAPITAL MANAGEMENT, LP | New Position | 134K | May 15, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | Increased | 118K | May 15, 2026 |
| PFIZER INC | Reduced | 102K | May 12, 2026 |
| BLACKROCK, INC. | Increased | 86K | May 13, 2026 |
Source: SEC Form 13F filings. For informational purposes only — not investment advice.